RYTHM Inc.
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Rayonier earns a Neutral rating, with a 45.0 composite score and low conviction of 2/5. Fundamentals provide the principal support at 70.0, driven by maximum subscores for year-over-year revenue growth and gross margin. Regulatory contributes a middling 49.0, combining a neutral jurisdiction posture, weak filing cadence, and a stronger enforcement subscore. Editorial registers 30.0 because CIN newsroom coverage contains no recent newsroom or brief activity. Market performance is the clear constraint at 15.0, reflecting the lowest liquidity tier and no reported trading volume. The pillar mix places Rayonier squarely in the Neutral band: commercial growth and gross profitability offset operating losses, stretched finances, limited disclosure activity, and negligible market participation.
Licensed fundamentals data show revenue growth of approximately 23.7% year over year, a pace that supports the 100.0 revenue-growth subscore. Gross margin stands near 68.3%, also earning a 100.0 subscore, but that strength fails to carry through the income statement. Operating margin is negative 30.4%, while net income records an approximately $11.7 million loss and EBITDA records an approximately $14.0 million loss. The resulting 53.6 operating-margin subscore, 36.5 cash-runway subscore, and 0.30 cash-burn ratio reinforce the stretched financial condition despite strong top-line and gross-margin readings. Primary regulatory filings show the latest filing dated June 18, 2026, no events during the latest 90-day period, and only one event across 180 days. That cadence produces a 25.0 subscore, while zero enforcement hits support the stronger 80.0 enforcement result.
The central forward catalyst sits within fundamentals, Rayonier’s strongest pillar. Continued revenue expansion paired with sustained gross margin creates a path toward better operating leverage, but the current negative operating margin and EBITDA loss demonstrate that conversion remains incomplete. Market confirmation also remains absent because institutional pricing feeds show no volume, while CIN newsroom coverage provides no incremental editorial signal. A stronger rating requires growth and gross profitability to translate into materially improved operating performance without worsening the stretched financial profile. The single most important signal to watch is a decisive improvement in operating margin alongside continued revenue growth.
- IR / PR agency
- Haus Comms
- IR email
- IR@RYTHMinc.com
- IR page
- Investor relations
- Headquarters
- 2220 HICKS ROAD, SUITE 210, ROLLING MEADOWS, IL, 60008
- Phone
- 855-420-0020
- CEO
- Benjamin Kovler (Interim CEO)
- CFO
- Brad Asher
- SEC CIK
- 1800637
- Website
- Company website
- Market cap
- $46.1M
- Enterprise value
- $94.1M
- Price to book
- 1.28
- Price to sales
- 1.54
- EV / EBITDA
- -1.73
- Revenue (TTM)
- $30.0M
- Gross profit (TTM)
- $20.5M
- EBITDA
- $-14.0M
- Operating margin
- -30.4%
- Profit margin
- -39.0%
- Rev growth YoY
- 2369.5%
- Return on equity
- -36.4%
- Return on assets
- -16.8%
- EPS (TTM)
- $-14.41
- Shares outstanding
- 2.1M
- Insider ownership
- 47.6%
- Institutional ownership
- 10.5%
- Beta
- 9.46
- Full-time employees
- 1
- GICS sector
- Consumer Defensive
- GICS industry
- Tobacco
- Annual report
- Latest 10-K
- Proxy statement
- Latest DEF 14A
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for RYTHM Inc. (RYM)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for RYTHM Inc. (RYM), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, insider selling. (1 bullish signal, 3 bearish signals.)
Latest price: $23.65 (+1.59%) on OTCMKTS.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for RYM are maintained by Cannabis Investor News and refreshed throughout the trading day.